Works by Popat, Rakesh

Results: 96
    1
    2
    3
    4
    5
    6

    Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.

    Published in:
    2020
    By:
    • Koutoukidis, Dimitrios A.;
    • Land, Joanne;
    • Hackshaw, Allan;
    • Heinrich, Malgorzata;
    • McCourt, Orla;
    • Beeken, Rebecca J.;
    • Philpott, Stephanie;
    • DeSilva, Dunnya;
    • Rismani, Ali;
    • Rabin, Neil;
    • Popat, Rakesh;
    • Kyriakou, Charalampia;
    • Papanikolaou, Xenofon;
    • Mehta, Atul;
    • Paton, Bruce;
    • Fisher, Abigail;
    • Yong, Kwee L.
    Publication type:
    journal article
    7
    8

    The impact of continuous lenalidomide maintenance treatment on people living with multiple myeloma—a single-centre, qualitative service evaluation study.

    Published in:
    Supportive Care in Cancer, 2024, v. 32, n. 7, p. 1, doi. 10.1007/s00520-024-08663-4
    By:
    • Buck, Caroline;
    • Brenes Castillo, Francisco;
    • Bettio, Elena;
    • Land, Joanne;
    • McCourt, Orla;
    • Poole, Helen;
    • Tarling, Rachel;
    • Yong, Kwee;
    • Popat, Rakesh;
    • Lee, Lydia;
    • McMillan, Annabel;
    • Papanikolaou, Xenofon;
    • Xu, Ke;
    • Kyriakou, Chara;
    • Rabin, Neil;
    • Wechalekar, Ashu;
    • Fisher, Abigail;
    • Sive, Jonathan
    Publication type:
    Article
    9

    The impact of COVID-19 on autologous stem cell transplantation in multiple myeloma: A single-centre, qualitative evaluation study.

    Published in:
    Supportive Care in Cancer, 2022, v. 30, n. 9, p. 7469, doi. 10.1007/s00520-022-07173-5
    By:
    • Camilleri, Marquita;
    • Bekris, Georgios;
    • Sidhu, Govundeep;
    • Buck, Caroline;
    • Elsden, Esma;
    • McCourt, Orla;
    • Horder, Jackie;
    • Newrick, Fiona;
    • Lecat, Catherine;
    • Sive, Jonathan;
    • Papanikolaou, Xenofon;
    • Popat, Rakesh;
    • Lee, Lydia;
    • Xu, Ke;
    • Kyriakou, Charalampia;
    • Rabin, Neil;
    • Yong, Kwee;
    • Fisher, Abigail
    Publication type:
    Article
    10
    11
    12
    13
    14

    High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00717-2
    By:
    • Khwaja, Jahanzaib;
    • Bomsztyk, Joshua;
    • Mahmood, Shameem;
    • Wisniowski, Brendan;
    • Shah, Raakhee;
    • Tailor, Anish;
    • Yong, Kwee;
    • Popat, Rakesh;
    • Rabin, Neil;
    • Kyriakou, Charalampia;
    • Sive, Jonathan;
    • Esposti, Simona Degli;
    • Larkin, Daniel F. P.;
    • Worthington, Sarah;
    • Hart, Alyse;
    • Dowling, Emma;
    • Correia, Nuno;
    • Bygrave, Ceri;
    • Rydzewski, Andrzej;
    • Jamroziak, Krzysztof
    Publication type:
    Article
    15
    16

    Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM).

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00494-4
    By:
    • Lonial, Sagar;
    • Nooka, Ajay K.;
    • Thulasi, Praneetha;
    • Badros, Ashraf Z.;
    • Jeng, Bennie H.;
    • Callander, Natalie S.;
    • Potter, Heather A.;
    • Sborov, Douglas;
    • Zaugg, Brian E.;
    • Popat, Rakesh;
    • Degli Esposti, Simona;
    • Byrne, Julie;
    • Opalinska, Joanna;
    • Baron, January;
    • Piontek, Trisha;
    • Gupta, Ira;
    • Dana, Reza;
    • Farooq, Asim V.;
    • Colby, Kathryn;
    • Jakubowiak, Andrzej
    Publication type:
    Article
    17

    Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.703233
    By:
    • Lecat, Catherine S. Y.;
    • Taube, Jessica B.;
    • Wilson, William;
    • Carmichael, Jonathan;
    • Parrish, Christopher;
    • Wallis, Gabriel;
    • Kyriakou, Charalampia;
    • Lee, Lydia;
    • Mahmood, Shameem;
    • Papanikolaou, Xenofon;
    • Rabin, Neil K.;
    • Sive, Jonathan;
    • Wechalekar, Ashutosh D.;
    • Yong, Kwee;
    • Cook, Gordon;
    • Popat, Rakesh
    Publication type:
    Article
    18
    19
    20

    PB2108: SPINAL INVOLVEMENT IS ASSOCIATED WITH HIGH INCIDENCE OF SKELETAL RELATED EVENTS AND INFERIOR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA. A SINGLE CENTRE EXPERIENCE IN 653 PATIENTS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000975216.90614.96
    By:
    • Kanellias, Nikolaos;
    • Parcharidou, Agapi;
    • Xu, Ke;
    • Americanou, Rodothea;
    • Benton, Adam;
    • Molloy, Sean;
    • Herzog, Jan;
    • Hargunani, Rigin;
    • Yong, Kwee;
    • Popat, Rakesh;
    • Sive, Jonathan;
    • Lee, Lydia;
    • Mcmilan, Annabel;
    • Papanikolaou, Xenofon;
    • Rabin, Neil;
    • Kyriakou, Charalampia
    Publication type:
    Article
    21
    22
    23
    24

    P868: MEZIGDOMIDE (MEZI) PLUS DEXAMETHASONE (DEX) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM THE DOSE‐EXPANSION PHASE OF THE CC‐92480‐MM‐001 TRIAL.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970376.71405.63
    By:
    • Bahlis, Nizar J;
    • Trudel, Suzanne;
    • Quach, Hang;
    • Popat, Rakesh;
    • Lonial, Sagar;
    • Orlowski, Robert Z;
    • Kim, Kihyun;
    • Mateos, Maria‐Victoria;
    • Pawlyn, Charlotte;
    • Ramasamy, Karthik;
    • Martinez‐Lopez, Joaquín;
    • Casas‐Avilés, Ignacio;
    • Spirli, Alessia;
    • Gong, Jing;
    • Amatangelo, Michael;
    • Katz, Jessica;
    • Maciag, Paulo;
    • Peluso, Teresa;
    • Richardson, Paul
    Publication type:
    Article
    25

    P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC‐2 STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970364.16259.0e
    By:
    • Tan, Carlyn;
    • Searle, Emma;
    • Anguille, Sébastien;
    • Bhutani, Manisha;
    • Biran, Noa;
    • Boyd, Kevin;
    • Cowan, Andrew;
    • Matous, Jeffrey;
    • Perrot, Aurore;
    • Berdeja, Jesus;
    • Janowski, Wojciech;
    • Popat, Rakesh;
    • Quach, Hang;
    • Schroeder, Mark;
    • Wong, Sandy W;
    • Vishwamitra, Deeksha;
    • Guo, Yue;
    • Niu, Zhuolu;
    • Larsen, Julie;
    • Chen, Lingling
    Publication type:
    Article
    26

    S100: FIRST PHASE 3 RESULTS FROM CARTITUDE‐4: CILTA‐CEL VERSUS STANDARD OF CARE (PVD OR DPD) IN LENALIDOMIDE‐REFRACTORY MULTIPLE MYELOMA.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967308.47141.6f
    By:
    • Einsele, Hermann;
    • Yong, Kwee;
    • Harrison, Simon;
    • Mateos, Maria‐Victoria;
    • Moreau, Philippe;
    • van de Donk, Niels W.C.J.;
    • Sidana, Surbhi;
    • Popat, Rakesh;
    • Lendvai, Nikoletta;
    • Lonardi, Carolina;
    • Slaughter, Ana;
    • Schecter, Jordan;
    • LI, Katherine;
    • Zudaire, Enrique;
    • Chen, Diana;
    • Gilbert, Jane;
    • Yeh, Tzu‐Min;
    • Pacaud, Lida;
    • Patel, Nitin;
    • Dhakal, Binod
    Publication type:
    Article
    27
    28

    P879: LONG-TERM FOLLOW-UP FROM MAJESTEC-1 OF TECLISTAMAB, A B-CELL MATURATION ANTIGEN (BCMA) X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM).

    Published in:
    2023
    By:
    • Sidana, Surbhi;
    • Moreau, Philippe;
    • Garfall, Alfred;
    • Bhutani, Manisha;
    • Oriol, Albert;
    • Nooka, Ajay;
    • Martin, Tom;
    • Rosiñol Dachs, Laura;
    • Mateos, Maria-Victoria;
    • Bahlis, Nizar J;
    • Popat, Rakesh;
    • Besemer, Britta;
    • Martinez-Lopez, Joaquín;
    • Krishnan, Amrita;
    • Delforge, Michel;
    • Trancucci, Danielle;
    • Verona, Raluca;
    • Stephenson, Tara;
    • Chastain, Katherine;
    • van de Donk, Niels W.C.J.
    Publication type:
    Abstract
    29
    30

    Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 8, p. 1465, doi. 10.1080/10428194.2023.2216817
    By:
    • Nesr, George;
    • Shah, Raakhee;
    • Kyriakou, Charalampia;
    • Sive, Jonathan;
    • Popat, Rakesh;
    • Yong, Kwee;
    • Wisniowski, Brendan;
    • Xu, Ke;
    • Wechalekar, Ashu;
    • Lee, Lydia;
    • Ings, Stuart;
    • Papanikolaou, Xenofon;
    • Mahmood, Shameem;
    • Mcmillan, Annabel;
    • Horder, Jackie;
    • Newrick, Fiona;
    • Marfil, Jotham;
    • Ainley, Louise;
    • Asher, Samir;
    • Cheesman, Simon
    Publication type:
    Article
    31

    Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 10, p. 2489, doi. 10.1080/10428194.2022.2074989
    By:
    • Howells, Lara;
    • Chan, Wei Yee;
    • Sanchez, Emilie;
    • Horder, Jacqueline;
    • Newrick, Fiona;
    • Marfil, Jotham;
    • McMillan, Annabel;
    • Wisniowski, Brendan;
    • Mahmood, Shameem;
    • Papanikolaou, Xenofon;
    • Lee, Lydia;
    • Wechalekar, Ashutosh;
    • Popat, Rakesh;
    • Sive, Jonathan;
    • Kyriakou, Charalampia;
    • Xu, Ke;
    • Nastouli, Eleni;
    • Yong, Kwee L.;
    • Rabin, Neil
    Publication type:
    Article
    32
    33
    34
    35

    Single‐agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM‐2 trial.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3746, doi. 10.1002/cncr.34987
    By:
    • Nooka, Ajay K.;
    • Cohen, Adam D.;
    • Lee, Hans C.;
    • Badros, Ashraf;
    • Suvannasankha, Attaya;
    • Callander, Natalie;
    • Abdallah, Al‐Ola;
    • Trudel, Suzanne;
    • Chari, Ajai;
    • Libby, Edward N.;
    • Chaudhry, Maria;
    • Hultcrantz, Malin;
    • Kortüm, K. Martin;
    • Popat, Rakesh;
    • Sborov, Douglas;
    • Hakim, Shawn;
    • Lewis, Eric;
    • Gorsh, Boris;
    • Bhushan, Bharat;
    • McKeown, Astrid
    Publication type:
    Article
    36
    37
    38
    39

    Re-transplantation after bortezomib-based therapy.

    Published in:
    British Journal of Haematology, 2011, v. 153, n. 5, p. 666, doi. 10.1111/j.1365-2141.2010.08521.x
    By:
    • Morris, Curly;
    • Cook, Gordon;
    • Streetly, Matthew;
    • Kettle, Paul;
    • Drake, Mary;
    • Quinn, Michael;
    • Cavet, Jim;
    • Tighe, Jane;
    • Kazmi, Majit;
    • Ashcroft, John;
    • Cook, Mark;
    • Snowden, John;
    • Olujohungbe, Ade;
    • Marshall, Scott;
    • Conn, Jane;
    • Oakervee, Heather;
    • Popat, Rakesh;
    • Cavenagh, Jamie
    Publication type:
    Article
    40
    41
    42
    43

    Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.

    Published in:
    Amyloid, 2020, v. 27, n. 3, p. 200, doi. 10.1080/13506129.2020.1765768
    By:
    • Cohen, Oliver C.;
    • Brodermann, Maximillian H.;
    • Blakeney, Iona J.;
    • Mahmood, Shameem;
    • Sachchithanantham, Sajitha;
    • Ravichandran, Sriram;
    • Law, Steven;
    • Lachmann, Helen J.;
    • Whelan, Carol J.;
    • Popat, Rakesh;
    • Rabin, Neil;
    • Yong, Kwee;
    • Kyriakou, Charalampia;
    • Shah, Raakhee;
    • Cheesman, Simon;
    • Worthington, Sarah;
    • Hawkins, Philip;
    • Gillmore, Julian D.;
    • Wechalekar, Ashutosh D.
    Publication type:
    Article
    44
    45
    46
    47
    48

    A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 2, p. 328, doi. 10.1111/bjh.18216
    By:
    • Ravichandran, Sriram;
    • Mahmood, Shameem;
    • Wisniowski, Brenden;
    • Sachchithanantham, Sajitha;
    • Popat, Rakesh;
    • Lachmann, Helen;
    • Rabin, Neil;
    • Ramasamy, Karthik;
    • Hawkins, Stephen;
    • Kyriakou, Charalampia;
    • Gillmore, Julian;
    • Yong, Kwee;
    • Hawkins, Philip;
    • Jackson, Graham;
    • Pratt, Guy;
    • D. Wechalekar, Ashutosh
    Publication type:
    Article
    49
    50

    Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial

    Published in:
    British Journal of Haematology, 2022, v. 196, n. 4, p. e33, doi. 10.1111/bjh.17903
    By:
    • Chan, Wei Yee;
    • Counsell, Nicholas;
    • de Tute, Ruth;
    • De‐Silva, Dunnya;
    • Phillips, Elizabeth H.;
    • Cavenagh, Jamie;
    • Adedayo, Toyin;
    • Braganca, Nivette;
    • Roddie, Claire;
    • Streetly, Matthew;
    • Schey, Stephen;
    • Koh, Mickey B.C.;
    • Crowe, Josephine;
    • Morris, Treen C.;
    • Cook, Gordon;
    • Clifton‐Hadley, Laura;
    • Rabin, Neil;
    • Owen, Roger G.;
    • Popat, Rakesh;
    • Yong, Kwee L.
    Publication type:
    Article